![Alan Au](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alan Au
Gründer bei
GT Capital Investment Ltd.
Profil
Alan Au is the founder of GT Capital Investment Ltd. founded in 2013, where he holds the title of General Partner.
He currently holds positions as Director at G.I.
Windows, Inc. and Advisor at Oxford Investment Consultants LLP.
Mr. Au previously held the position of Board Member at Cellular Biomedicine Group (Shanghai) Ltd. from 2014 to 2021 and Board Member at I-MAB Biopharma Co., Ltd. Mr. Au received his undergraduate degree from The Chinese University of Hong Kong in 1994 and his MBA from Columbia Business School in 2007.
Aktive Positionen von Alan Au
| Unternehmen | Position | Beginn |
|---|---|---|
GT Capital Investment Ltd.
 GT Capital Investment Ltd. Investment ManagersFinance GT Healthcare Capital Partners is an active manager which invests in companies located in China (People's Republic). It participates in early stage transactions and focuses on sectors such as Health Technology and Health Services. | Gründer | 01.01.2013 |
Oxford Investment Consultants LLP
 Oxford Investment Consultants LLP Investment ManagersFinance Oxford Investment Consultants invests in companies located in the United Kingdom. The firm focuses on companies operating in the life sciences, deep tech and physical sectors sectors. It participates in seed and early stage capital requirements. | Berater | - |
G.I. Windows, Inc.
 G.I. Windows, Inc. Medical SpecialtiesHealth Technology Manufactures surgical anastomotic systems | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Alan Au
| Unternehmen | Position | Ende |
|---|---|---|
Cellular Biomedicine Group (Shanghai) Ltd.
 Cellular Biomedicine Group (Shanghai) Ltd. BiotechnologyHealth Technology Engages in the development of effective treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies | Direktor/Vorstandsmitglied | 01.02.2021 |
I-MAB Biopharma Co., Ltd.
 I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology Operates as biotechnology company focuses on cancer immunity and autoimmune disease treatment | Direktor/Vorstandsmitglied | - |
Ausbildung von Alan Au
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
97
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
G.I. Windows, Inc.
G.I. Windows, Inc. Medical SpecialtiesHealth Technology Manufactures surgical anastomotic systems | Health Technology |
The Chinese University of Hong Kong
 The Chinese University of Hong Kong Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford Investment Consultants LLP
Oxford Investment Consultants LLP Investment ManagersFinance Oxford Investment Consultants invests in companies located in the United Kingdom. The firm focuses on companies operating in the life sciences, deep tech and physical sectors sectors. It participates in seed and early stage capital requirements. | Finance |
Cellular Biomedicine Group (Shanghai) Ltd.
Cellular Biomedicine Group (Shanghai) Ltd. BiotechnologyHealth Technology Engages in the development of effective treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies | Health Technology |
GT Capital Investment Ltd.
GT Capital Investment Ltd. Investment ManagersFinance GT Healthcare Capital Partners is an active manager which invests in companies located in China (People's Republic). It participates in early stage transactions and focuses on sectors such as Health Technology and Health Services. | Finance |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology Operates as biotechnology company focuses on cancer immunity and autoimmune disease treatment | Health Technology |
